The project’s abstract states that: “Our laboratory has been working with the use of inhalation and oral delivery of anticancer agents for treatment of lung cancer. Active targeting of chemotherapeutic drugs containing nanoparticles may effectively treat adenocarcinomas by achieving higher concentration at target sites.”
A nanoparticle is a microscopic object that is between 0.1nm and 100nm. Sachdeva is exploring how an experimental treatment that combines the use of certain nanoparticles with a drug named Telmisartan might improve the body's ability to fight cancer.
The project began on April 1, 2014 and will continue through March 31, 2016.
Sacheva has brought more than $25 million in research grants to FAMU since he began teaching at the university in 1993.